Article

CMS Announces Changes to Dialysis ACO Application

The Centers for Medicare & Medicaid Services Innovation Center held an Open Door Forum on Aug. 1 to announce some modifications to the application for the Comprehensive ESRD Initiative, or renal-specific Accountable Care Organization demonstration.

The Centers for Medicare & Medicaid Services Innovation Center held an Open Door Forum on Aug. 1 to announce some modifications to the application for the Comprehensive ESRD Initiative, or renal-specific Accountable Care Organization demonstration.

The agency said it plans to launch the demonstration in January, shortly after approving the applications for the project. The agency recently extended the application deadline to August 30.

Other updates to the application include:

  • CMS now requires that only an independent nephrologist or nephrology group practice join a dialysis facility to create a legal participating entity. Previously, an additional Medicare provider or supplier would have been required for an application.
  • CMS made changes to the risk arrangement for large dialysis organizations. The guaranteed discount for those participants is 0% in year one, 1% in year two, 2% in year three, and 3% in year four and beyond.
  • CMS also made changes to the rebasing methodology, which takes place in the fourth payment year. Rebasing will now consider an average of total annual expenditures for the three previous years as a base.
  • CMS clarified that waivers granted in this demonstration will apply to all participating organizations.

Read the full story here: http://bit.ly/16peWcI

Source: NNI

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Richard Lafayette, MD, FACP, Stanford University Medical Center
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo